Literature DB >> 2275606

Vitamin A supplementation increases levels of retinoic acid compounds in human plasma: possible implications for teratogenesis.

C Eckhoff1, H Nau.   

Abstract

The concentrations of retinoic acid compounds were monitored by a newly developed highly sensitive HPLC procedure in plasma of six volunteers who received 833 IU vitamin A per kg body weight per day during a 20-day period. There was a significant increase of all-trans-retinoic acid (two-fold), 13-cis-retinoic acid (7-fold) and 13-cis-4-oxoretinoic acid (5-fold) over endogenous plasma levels of these retinoids. The same compounds had previously been found after treatment with the teratogenic drug isotretinoin (Roaccutan, Accutane). Our results raise the possibility that high vitamin A intake may carry a teratogenic risk attributable to increased levels of retinoic acid compounds generated from retinol by metabolic processes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2275606     DOI: 10.1007/bf01977634

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  13 in total

1.  Determination of isotretinoin or etretinate and their major metabolites in human blood by reversed-phase high-performance liquid chromatography.

Authors:  C J Buggé; L C Rodriguez; F M Vane
Journal:  J Pharm Biomed Anal       Date:  1985       Impact factor: 3.935

2.  Identification of a receptor for the morphogen retinoic acid.

Authors:  V Giguere; E S Ong; P Segui; R M Evans
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

3.  Teratology Society position paper: recommendations for vitamin A use during pregnancy.

Authors: 
Journal:  Teratology       Date:  1987-04

Review 4.  Influence of sex on drug kinetics in man.

Authors:  J F Giudicelli; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

5.  Pharmacokinetics of isotretinoin during repetitive dosing to patients.

Authors:  R K Brazzell; F M Vane; C W Ehmann; W A Colburn
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Identification and quantitation of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma.

Authors:  C Eckhoff; H Nau
Journal:  J Lipid Res       Date:  1990-08       Impact factor: 5.922

7.  Retinoic acid embryopathy.

Authors:  E J Lammer; D T Chen; R M Hoar; N D Agnish; P J Benke; J T Braun; C J Curry; P M Fernhoff; A W Grix; I T Lott
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

Review 8.  Hypervitaminosis A induced teratogenesis.

Authors:  J A Geelen
Journal:  CRC Crit Rev Toxicol       Date:  1979-11

9.  Transplacental pharmacokinetics and teratogenicity of a single dose of retinol (vitamin A) during organogenesis in the mouse.

Authors:  C Eckhoff; B Löfberg; I Chahoud; G Bochert; H Nau
Journal:  Toxicol Lett       Date:  1989-08       Impact factor: 4.372

Review 10.  Clinical pharmacokinetics of the retinoids.

Authors:  R W Lucek; W A Colburn
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

View more
  4 in total

Review 1.  Micronutrient supplementation in pregnancy: Who, what and how much?

Authors:  F Parisi; I di Bartolo; V M Savasi; I Cetin
Journal:  Obstet Med       Date:  2018-05-04

Review 2.  Functions of Intracellular Retinoid Binding-Proteins.

Authors:  Joseph L Napoli
Journal:  Subcell Biochem       Date:  2016

3.  Hyperglycaemia potentiates the teratogenicity of retinoic acid in diabetic pregnancy in mice.

Authors:  M B W Leung; K-W Choy; A J Copp; C-P Pang; A S W Shum
Journal:  Diabetologia       Date:  2004-02-14       Impact factor: 10.122

4.  No effect of vitamin A intake on bone mineral density and fracture risk in perimenopausal women.

Authors:  L Rejnmark; P Vestergaard; P Charles; A P Hermann; C Brot; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2004-03-18       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.